ข้อมูลจาก Google Scholar

• 0, The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens
  CPT: Pharmacometrics & Systems Pharmacology 14 (1), 95-104, 2025
• 0, Optimized fosfomycin regimens for treating carbapenem‐resistant Acinetobacter baumannii in critically ill patients with varying degrees of renal function
  Clinical and Translational Science 17 (10), e70038, 2024
• 0, Determination of pharmacokinetic parameters and factors influencing the pharmacokinetic parameters of phenytoin in Thai children with epilepsy
  Int J Pharm Pharm Sci 13 (1), 47-51, 2021
• 0, The Association Between Genetic Polymorphisms of UGT1A1, ABCG2, and NR1I2 and Dolutegravir Pharmacokinetic Parameters in Thai People Living with HIV
  Pharmaceutics 17 (11), 1499, 2025
• 0, Genetic polymorphisms of UGT1A1, ABCG2, NR1I2 and SLC22A2 in Thai people living with HIV: comparative analysis with other populations.
  Natural and Life Sciences Communications 24 (2), e2025024, 2025
• 0, Impact of Body Weight and Combined UGT1A1 and NR1I2 Polymorphisms on Dolutegravir Pharmacokinetics Among Thai People Living with HIV: A Population …
  Pharmaceutics 18 (10), 1245, 2026
• 0, Population Approach Group Europe Population Approach Group Europe